fbpx
QQQ
+ 0.56
283.62
+ 0.2%
DIA
-0.40
284.13
-0.14%
SPY
+ 0.98
343.66
+ 0.28%
TLT
+ 0.96
156.09
+ 0.61%
GLD
-0.17
179.00
-0.1%

MediPharm Labs Inks Exclusive Supply Agreement With Germany's STADA

October 5, 2020 5:44 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Medical cannabis company MediPharm Labs Corp. (TSX:LABS) (OTCQX:MEDIF) agreed to supply GMP-certified medical cannabis products to German pharmaceutical giant Stada Arzneimittel AG.

Under the agreement, MediPharm will also provide manufacturing, logistics, and regulatory support.

The partnership will begin in Germany, but is expected to expand to other European countries and territories where Stada has presence.

The German manufacturer sells its products in approximately 120 countries globally.

Opportunities in Germany and Beyond

The German market currently represents around three-quarters of Europe’s medical marijuana market, with over 83 million inhabitants and broad access to healthcare services.

The medical cannabis market in Germany is valued today at between €150 million and €175 million. Analysts anticipate this market to grow to €1.5 billion by 2025.

According to MediPharm CEO Pat McCutcheon, Germany relies heavily on international imports since the country is not due for their first batch of domestic harvests until next year. 

“MediPharm Labs and Stada will effectively leapfrog these challenges through this important collaboration. Getting to market quickly and with innovative quality formulations will make us trusted go-to providers," he said.

Bain Capital (NYSE:BCSF) gained control of Stada in 2017 thanks to a joint acquisition with private equity fund Cinven. This partnership marks Bain’s first incursion into the cannabis industry.

Lead image by Ilona Szentivanyi. Copyright: Benzinga.


Related Articles

The Week In Cannabis: Stocks Outperform, Michigan Shapes Up As New Leader, Celeb Brands Get Hot

Cannabis stocks traded up in a relatively slow news week, where celebrity brands grabbed headlines. read more

Cannabis Stock Gainers And Losers From October 23, 2020

GAINERS: CB2 Insights (OTCQB: CBIIF) shares closed up 15.07% at $0.45 read more

Centri Business Consulting Moderates Panel On Game-Changing Technology For Cannabis Consumers

This special presentation from Centri Business Consulting comes from Benzinga’s Virtual Cannabis Capital Conference that took place on October 15. read more

Cannabis Stock Gainers And Losers From October 22, 2020

GAINERS: BioHarvest Sciences (PINK: CNVCF) shares closed up 13.64% at $0.13 read more

Cannabis Brands Get Loud With Rock-Branded Weed Featuring Santana, Jerry Garcia

The list of musicians hawking cannabis products is a long one. Willie Nelson, Margo Price, Snoop Dogg and Berner are just some of the names that come to mind. read more